Status:
COMPLETED
The Effect of Vitamin B3 on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men
Lead Sponsor:
Aarhus University Hospital
Collaborating Sponsors:
University of Copenhagen
Conditions:
Obese
Eligibility:
MALE
40-70 years
Phase:
NA
Brief Summary
In animals, treatment with vitamin B3 improved insulin sensitivity and substrate metabolism. It is currently not know if vitamin B3 has the same positive effects in humans. In the current study the ef...
Eligibility Criteria
Inclusion
- written signed consent
- male
- BMI\>30 kg/(m2)
- age: 40-70
- no medication
- non-smoker
Exclusion
- endocrine disease
- other severe disease
- high daily activity level (\>30 min / day)
Key Trial Info
Start Date :
January 4 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 4 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02303483
Start Date
January 4 2016
End Date
April 4 2017
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Research Laboratories, Aarhus University Hospital
Aarhus, Denmark, 8000